Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Diabetics promised painless glucose monitoring systems

This article was originally published in Clinica

Executive Summary

Karen Drexler, president and CEO of Amira Medical, believes that the finger stick pain associated with glucose testing will be a thing of the past. She told a recent Chase Hambrecht & Quest healthcare conference in San Francisco that it was an "archaic method, upon which this whole multi-billion dollar market is based". The market is about to change, she predicted, with a series of solutions to introduce painless glucose monitoring.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT073119

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel